SCHEMBL4746019

SCHEMBL4746019

Cc1ccc2c(c1)c(-c1ccc3cccnc3c1)cc1c3ccc(C)c4c3c(cc21)-c1ncccc1-4

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
MAPK14 Q16539 1/20 0.38
TGFBR1 P36897 4/20 0.36
CCNC P24863 1/20 0.34
CDK8 P49336 1/20 0.34
DHODH Q02127 1/20 0.34
CCR1 P32246 1/20 0.32
CCR5 P51681 1/20 0.32
CCR8 P51685 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
PDE10A Q9Y233 1/20 0.32
ADORA2A P29274 1/20 0.31
MEN1 O00255 1/20 0.31
CASP1 P29466 1/20 0.31
CASP7 P55210 1/20 0.31
KMT2A Q03164 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2C19 P33261 1/20 0.31
HTT P42858 1/20 0.31
NR4A2 P43354 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4746018 0.92 ALDH1A1 (0.44) ALDH1A1TGFBR1CCNCCDK8DHODH
SCHEMBL4746389 0.92 DHODH (0.34) ALDH1A1TGFBR1DHODHCCR1CCR5
SCHEMBL4745812 0.91 ALDH1A1 (0.34) ALDH1A1DHODHCCR1CCR5CCR8
SCHEMBL13320352 0.91 ALDH1A1 (0.45) ALDH1A1MAPK14TGFBR1CCNCCDK8
SCHEMBL4746387 0.91 DHODH (0.33) ALDH1A1TGFBR1DHODHCCR1CCR5
SCHEMBL4746339 0.89 DHODH (0.36) ALDH1A1TGFBR1DHODHMEN1KMT2A
SCHEMBL4746317 0.88 DHODH (0.35) ALDH1A1DHODHMEN1KMT2A
SCHEMBL4746310 0.87 BCHE (0.34) ALDH1A1TGFBR1CDK8DHODHMEN1
SCHEMBL4745912 0.86 TGFBR1 (0.31) TGFBR1DHODH
SCHEMBL4746312 0.85 BCHE (0.34) ALDH1A1TGFBR1DHODHMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173275-B2 Azaindenochrysene derivative and organic light-emitting device CANON KABUSHIKI KAISHA (JP) 2012-05-08 US disclosed
US-8173275-B2 Azaindenochrysene derivative and organic light-emitting device CANON KABUSHIKI KAISHA (JP) 2012-05-08 US disclosed
US-20100117526-A1 NOVEL AZAINDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2010-05-13 US disclosed
US-20100117526-A1 NOVEL AZAINDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2010-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100117526-A1 NOVEL AZAINDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE NR2E3, OR51E2, AZI2 ALDH1A1 179/4885MAPK14 3331/4885TGFBR1 1895/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.